Search

Your search keyword '"Morita M"' showing total 1,537 results

Search Constraints

Start Over You searched for: Author "Morita M" Remove constraint Author: "Morita M" Publication Year Range Last 10 years Remove constraint Publication Year Range: Last 10 years
1,537 results on '"Morita M"'

Search Results

1. A hole-Cr$^{+}$ nano-magnet in a semiconductor quantum dot

2. Radio-frequency stress-induced modulation of CdTe/ZnTe quantum dots

3. Influence of non-equilibrium phonons on the spin dynamics of a single Cr atom

6. Involvement of the Speech-Language-Hearing Therapist in Tracheoesophageal Cancer Treatment at NHO Kyushu Cancer Center

7. Risk Assessment for Elderly Patients with Esophageal Cancer

11. Comparative study of GeO2/Ge and SiO2/Si structures on anomalous charging of oxide films upon water adsorption revealed by ambient-pressure X-ray photoelectron spectroscopy

16. Being Praised for Prosocial Behaviors Longitudinally Reduces Depressive Symptoms in Early Adolescents: A Population-Based Cohort Study

22. Novel Functional Peptide for Next-Generation Vital Pulp Therapy

25. The Solar System calcium isotopic composition inferred from Ryugu samples

31. Chemical and isotopic characterization of Asteroid Ryugu

32. In-situ Oxygen and Manganese-Chromium Isotope studies of Ryugu: Implications to temperature and timing of aqueous activity

33. The Oxygen Isotopic Composition of Samples returned from, Asteroid Ryugu: Evidence for similarity to CI Chondrites

34. Multi-Isotopic Analyses of Bulk Ryugu Samples returned by the Hayabusa2 Mission

35. Sampling Mass and Chemical Heterogeneities Among Ryugu Samples Returned by the Hayabusa2 Mission

37. The Solar System calcium isotopic composition inferred from Ryugu samples

38. Novel Functional Peptide for Next-Generation Vital Pulp Therapy.

42. AI Diagnosis of TP53 IHC for Detecting TP53 Mutational Types

44. sj-docx-1-jdr-10.1177_00220345221135766 – Supplemental material for Novel Functional Peptide for Next-Generation Vital Pulp Therapy

47. ‘Minimal symptom expression’ in patients with acetylcholine receptor antibody-positive refractory generalized myasthenia gravis treated with eculizumab

48. Consistent improvement with eculizumab across muscle groups in myasthenia gravis

50. 1306P Real-world data of first-line treatment with pembrolizumab for highly PD-L1 expressing NSCLC (HOT/NJLCG2001)

Catalog

Books, media, physical & digital resources